Xeris Biopharma Holdings, Inc.

XERS

Xeris Biopharma Holdings, Inc.

XERS

Insider Sentiment (TTM):

Last Purchase:2025-06-13Last Sale:2026-06-04Shares Purchased (TTM):0Shares Sold (TTM):481,951

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:91,489,233Shares Outstanding:170,523,208Institutional Ownership Pct.:53.65%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Accounts Receivable Net Current	58	56	51	54	53	46	40	41	42	37	39	46
Inventory Net	81	74	69	67	67	53	48	45	43	41	39	38
Short Term Investments	-	-	-	-	-	-	0	10	20	25	5	20
Prepaid Expense Current	14	9	10	11	6	6	7	7	7	8	6	8
Assets Current	275	252	240	224	186	163	168	163	170	173	156	158
Property Plant And Equipment Net	5	5	5	5	5	5	6	6	6	6	6	6
Operating Lease Right Of Use Asset	22	22	22	22	22	23	23	23	23	23	23	23
Goodwill	23	23	23	23	23	23	23	23	23	23	23	23
Intangible Assets Net Excluding Goodwill	83	85	88	91	94	96	99	102	104	107	110	112
Other Assets Noncurrent	5	5	5	5	5	5	5	5	5	5	5	5
Assets	412	392	384	370	335	315	323	321	332	337	323	328
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	11	3	7	9	6	2	7	6	7	12	12
Long Term Debt Current	-	-	0	0	0	12	15	15	-	-	0	-
Operating Lease Liability Current	6	6	6	6	6	6	6	6	5	5	3	2
Accrued Liabilities Current	40	32	33	30	25	20	28	24	23	22	24	19
Other Liabilities Current	5	4	5	3	2	0	1	1	1	1	1	1
Liabilities Current	190	119	110	116	95	95	100	91	75	73	95	87
Long Term Debt	-	-	-	-	-	-	-	216	230	230	191	190
Long Term Debt Noncurrent	189	221	220	219	219	218	217	-	-	-	191	-
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	0	0	0	1	19	18
Operating Lease Liability Noncurrent	31	31	32	32	32	33	33	34	34	34	35	35
Other Liabilities Noncurrent	13	8	8	3	8	5	2	9	8	6	5	4
Liabilities	422	379	370	371	354	351	353	349	351	346	329	324
Stockholders Equity Defic…
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	0	0	0	0	1	5
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Income Tax Liabilities Net	-	-	-	-	-	-	0	0	3	3	2	3
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	690	682	685	682	664	646	642	638	632	627	610	608
Retained Earnings Accumulated Deficit	-700	-669	-671	-682	-683	-681	-672	-667	-651	-636	-617	-604
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	-10	13	14	-1	-19	-35	-30	-28	-19	-9	-7	4
Liabilities And Stockholders Equity	412	392	384	370	335	315	323	321	332	337	323	328
Cash And Cash Equivalents At Carrying Value	122	112	111	92	59	58	72	59	58	63	67	46
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	350	350	350	350	350	350	350	350	350	350	350	350
Common Stock Shares Issued	174	173	166	166	161	156	149	149	149	148	138	138
Shares Outstanding	174	173	166	166	161	156	149	149	149	148	138	138

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.09%	15.99%	25.49%	-	-	-	-	-	-	-	-	-
2025	-4.26%	-8.91%	-2.71%	18.64%	23.94%	39.55%	-6.87%	-4.41%	-3.50%	-10.30%	0.50%	2.82%
2024	-	-	-	26.01%	28.70%	43.50%	-5.48%	-1.15%	-0.58%	20.21%	19.68%	38.83%
2023	-	-	-	-	-	-	4.42%	29.83%	37.57%	-8.14%	-27.91%	-37.60%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.45	2.12	2.19	1.93	1.95	1.72	1.67	1.79	2.26	1.67	1.64	1.82
Quick Ratio	0.95	1.42	1.48	1.25	1.18	1.10	1.12	1.21	1.59	1.12	1.17	1.29
Working Capital	85.19M	133.09M	130.74M	107.82M	90.41M	68.42M	67.22M	71.79M	94.85M	67.22M	61.07M	71.01M
Leverage & Debt
Debt to Equity	-43.32	29.13	27.02	-430.95	-18.34	-9.98	-11.91	-12.34	-18.20	-11.91	-48.57	83.81
Interest Coverage TTM	1.30	1.25	0.86	-0.12	-0.65	-0.97	-1.23	-1.71	-1.56	-1.79	-1.85	-1.55
Debt Ratio	1.02	0.97	0.96	1.00	1.06	1.11	1.09	1.09	1.06	1.09	1.02	0.99
Efficiency & Turnover
Asset Turnover TTM	0.90	0.89	0.83	0.89	0.86	0.82	0.94	0.98	0.96	1.18	1.18	0.99
Days Sales Outstanding TTM	60.48	59.49	57.20	56.45	60.79	60.15	47.82	49.88	47.64	38.21	32.35	42.89
Receivables Turnover TTM	6.04	6.14	6.38	6.47	6.00	6.07	7.63	7.32	7.66	9.55	11.28	8.51
Per Share Metrics
Diluted EPS TTM	-0.10	0.07	0.00	-0.19	-0.32	-0.42	-0.54	-0.70	-0.68	-0.93	-1.18	-0.91
Free Cash Flow Per Share TTM	0.21	0.28	0.18	0.13	-0.04	-0.31	-0.24	-0.20	-0.51	-0.26	-0.23	-0.40
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	86.58%	85.89%	85.41%	84.66%	82.67%	82.69%	82.79%	82.03%	83.41%	83.03%	82.40%	82.29%
Operating Profit Margin TTM	10.91%	11.40%	8.53%	-1.45%	-8.40%	-13.96%	-15.21%	-22.83%	-20.71%	-25.16%	-30.93%	-31.43%
Net Profit Margin TTM	-5.12%	3.81%	0.19%	-11.29%	-17.78%	-24.34%	-25.98%	-32.92%	-32.41%	-35.88%	-41.10%	-40.06%
Growth Metrics
Net Revenue Growth (1Y)	17.01%	19.63%	-3.94%	-3.73%	-8.33%	-30.78%	-23.11%	1.92%	6.35%	86.61%	258.38%	170.38%
Net Income Growth (1Y)	-66.33%	-118.75%	-100.70%	-67.00%	-49.70%	-53.04%	-51.39%	-16.25%	-24.86%	22.88%	71.55%	-29.81%
EPS Growth (1Y)	-68.93%	-116.76%	-100.64%	-69.95%	-53.21%	-54.79%	-54.41%	-22.39%	-30.27%	15.27%	69.00%	-30.88%
Valuation Metrics
P/E TTM	-79.74	82.36	2,273.17	-38.48	-14.61	-13.07	-6.30	-4.05	-3.29	-2.38	-1.99	-2.05
P/B TTM	-140.62	76.02	92.00	-1,547.17	-38.58	-23.83	-16.80	-14.99	-17.31	-10.95	-47.71	66.44
P/S TTM	4.08	3.14	4.32	4.34	2.60	3.18	1.64	1.33	1.07	0.85	0.82	0.82
Market Cap	1.37B	989.03M	1.26B	1.33B	744.68M	836.93M	497.56M	424.63M	333.78M	324.37M	323.54M	256.79M
Enterprise Value	1.43B	1.09B	1.36B	1.46B	899.89M	1.00B	662.75M	577.50M	502.43M	487.13M	459.14M	396.65M
Calculated Values
Free Cash Flow TTM	36.71M	48.53M	28.63M	20.59M	-6.15M	-47.01M	-35.01M	-29.51M	-75.70M	-37.58M	-32.08M	-55.67M
Net Debt	63.04M	105.45M	105.27M	123.85M	155.22M	167.20M	165.19M	152.87M	168.65M	162.76M	135.60M	139.85M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-04Sale

Owner: Halkuff, Dawn

Title: -

Shares: 20,000

Price/Share: $6.09

Value: $121,800.00

Shares Owned: 95,000

Relationship: Director

Ownership: Direct

2026-06-04Sale

Owner: Bormann-Kennedy, Barbara-…

Title: -

Shares: 16,000

Price/Share: $6.09

Value: $97,440.00

Shares Owned: 126,500

Relationship: Director

Ownership: Direct

2026-06-04Sale

Owner: Johnson, John

Title: -

Shares: 15,000

Price/Share: $6.09

Value: $91,350.00

Shares Owned: 683,083

Relationship: Director

Ownership: Direct

2026-06-03Sale

Owner: Persky, Marla

Title: -

Shares: 15,500

Price/Share: $5.90

Value: $91,450.00

Shares Owned: 126,500

Relationship: Director

Ownership: Direct

2026-06-01Sale

Owner: Hecht, Beth

Title: See Remarks

Shares: 16,667

Price/Share: $6.06

Value: $101,002.02

Shares Owned: 1,176,506

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-04	Halkuff, Dawn	Director	-	Direct	Sale	20,000	6.09	$121,800.00	95,000	4
2026-06-04	Bormann-Kennedy, Barbara-…	Director	-	Direct	Sale	16,000	6.09	$97,440.00	126,500	4
2026-06-04	Johnson, John	Director	-	Direct	Sale	15,000	6.09	$91,350.00	683,083	4
2026-06-03	Persky, Marla	Director	-	Direct	Sale	15,500	5.90	$91,450.00	126,500	4
2026-06-01	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	6.06	$101,002.02	1,176,506	4
2026-05-01	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	6.23	$103,835.41	1,193,173	4
2026-04-01	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	5.99	$99,835.33	1,209,840	4
2026-03-30	Brady, James Aloysius	Director	-	Direct	Sale	10,834	5.54	$60,020.36	89,166	4
2026-03-02	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	6.65	$110,835.55	1,226,507	4
2026-02-02	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	7.45	$124,169.15	1,243,174	4
2026-01-08	Mcculloch, Kevin	Officer	See Remarks	Direct	Sale	15,000	8.00	$120,000.00	1,685,426	4
2026-01-05	Shannon, John Patrick Jr	Director,Officer	See Remarks	Direct	Sale	24,907	7.08	$176,341.56	2,705,346	4
2026-01-02	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	7.43	$123,835.81	1,308,103	4
2025-12-19	Johnson, John	Director	-	Direct	Sale	135,400	7.22	$977,588.00	698,083	4
2025-12-12	Bormann-Kennedy, Barbara-…	Director	-	Direct	Sale	15,000	7.09	$106,350.00	142,500	4
2025-12-01	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	7.01	$116,835.67	1,320,176	4
2025-11-13	Shannon, John Patrick Jr	Director,Officer	See Remarks	Direct	Sale	23,242	7.46	$173,385.32	2,643,153	4
2025-11-11	Hecht, Beth	Officer	See Remarks	Direct	Sale	16,667	7.40	$123,335.80	1,336,843	4
2025-09-11	Persky, Marla	Director	-	Direct	Sale	15,500	7.72	$119,660.00	142,000	4
2025-08-28	Sherman, Jeffrey W	Director	-	Direct	Sale	42,232	7.92	$334,477.44	219,188	4
2025-08-13	Johnson, John	Director	-	Direct	Sale	107,500	7.32	$786,900.00	833,483	4
2025-08-12	Halkuff, Dawn	Director	-	Direct	Sale	42,500	7.28	$309,400.00	115,000	4
2025-06-13	Mcculloch, Kevin	Officer	See Remarks	Direct	Purchase	25,000	4.38	$109,500.00	1,708,585	4
2025-03-20	Hecht, Beth	Officer	See Remarks	Direct	Sale	40,000	5.43	$217,200.00	1,353,510	4
2024-08-12	Schmid, John P.	Director	-	Indirect	Purchase	4,515	2.25	$10,158.75	25,200	4
2024-08-09	Schmid, John P.	Director	-	Indirect	Purchase	4,285	2.37	$10,155.45	20,685	4
2024-05-10	Schmid, John P.	Director	-	Indirect	Purchase	5,400	1.91	$10,314.00	16,400	4
2024-03-14	Schmid, John P.	Director	-	Indirect	Purchase	4,500	2.16	$9,720.00	11,000	4
2023-11-27	Sherman, Jeffrey W	Director	-	Indirect	Purchase	5,400	1.87	$10,098.00	5,400	4
2023-11-20	Halkuff, Dawn	Director	-	Indirect	Purchase	5,410	1.84	$9,954.40	5,410	4
2023-11-20	Pieper, Steven	Officer	See Remarks	Direct	Purchase	28,000	1.95	$54,600.00	1,176,912	4
2023-11-17	Shannon, John Patrick Jr	Officer	See Remarks	Direct	Purchase	30,769	1.64	$50,461.16	1,408,575	4
2023-11-16	Schmid, John P.	Director	-	Indirect	Purchase	6,500	1.51	$9,815.00	6,500	4
2023-11-14	Persky, Marla	Director	-	Indirect	Purchase	6,370	1.58	$10,064.60	6,370	4
2023-08-09	Edick, Paul R	Director,Officer	See Remarks	Direct	Purchase	10,000	2.38	$23,800.00	2,288,064	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

53.65%

Inst. Shares: 91,489,233

Shares Outstanding: 170,523,208

2025-12-31

61.19%

Inst. Shares: 98,160,991

Shares Outstanding: 160,425,198

2025-09-30

58.12%

Inst. Shares: 95,120,146

Shares Outstanding: 163,649,932

2025-06-30

55.56%

Inst. Shares: 88,592,768

Shares Outstanding: 159,459,413

2025-03-31

55.93%

Inst. Shares: 85,264,657

Shares Outstanding: 152,445,935

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	91,489,233	170,523,208	53.65%
2025-12-31	98,160,991	160,425,198	61.19%
2025-09-30	95,120,146	163,649,932	58.12%
2025-06-30	88,592,768	159,459,413	55.56%
2025-03-31	85,264,657	152,445,935	55.93%
2024-12-31	63,809,096	146,772,758	43.47%
2024-09-30	60,765,917	148,993,823	40.78%
2024-06-30	57,142,382	148,345,549	38.52%
2024-03-31	56,658,388	140,513,907	40.32%
2023-12-31	55,851,180	137,674,857	40.57%
2023-09-30	51,538,976	138,059,781	37.33%
2023-06-30	53,190,294	137,338,071	38.73%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Xeris Biopharma Holdings, Inc. (XERS) — SEC Financial Statements & Analysis

Xeris Biopharma Holdings, Inc. (XERS) is a pharmaceutical preparations company. Xeris Biopharma Holdings, Inc. trades on Nasdaq as: XERS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Xeris Biopharma Holdings, Inc. reported a 17.01% year-over-year revenue growth, a Gross Profit Margin of 86.58% (TTM), a Debt-to-Equity ratio of -43.32x, a Price-to-Sales (P/S) ratio of 4.08x (TTM), a Price-to-Book (P/B) ratio of -140.62x (TTM), at a market cap of $1.37B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 17.01%
Gross Profit Margin TTM: 86.58%
Debt To Equity: -43.32x
P/S TTM: 4.08x
P/B TTM: -140.62x
Market Cap: $1.37B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Xeris Biopharma Holdings, Inc. in?

Xeris Biopharma Holdings, Inc. (XERS) operates in the Pharmaceutical Preparations industry.

What is XERS's market cap?

Xeris Biopharma Holdings, Inc. (XERS) has a market capitalization of $1.37B as of 2026-06-30.

What exchange does XERS trade on?

Xeris Biopharma Holdings, Inc. (XERS) trades on the Nasdaq.